Oruka Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORKA research report →
About the company
Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions.
- CEO
- Lawrence Otto Klein
- IPO
- 1997
- Employees
- 28
- HQ
- Menlo Park, MA, US
Price Chart
- Market Cap
- $3.19B
- P/E
- -35.65
- P/S
- 0.00
- P/B
- 9.66
- EV/EBITDA
- -27.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -25.99%
- ROIC
- -27.31%
- Revenue
- $0 · 0.00%
- Net Income
- $-105,433,000 · -25.93%
- EPS
- $-2.31 · 53.71%
- Op Income
- $-122,051,000
- FCF YoY
- -52.38%
- 52W High
- $97.78
- 52W Low
- $12.48
- 50D MA
- $68.72
- 200D MA
- $41.96
- Beta
- -0.40
- Avg Volume
- 1.83M
Get TickerSpark's AI analysis on ORKA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Fairmount Funds Management LLC | other | 3,553,410 |
| Jul 1, 26 | Fairmount Funds Management LLC | sell | 3,553,410 |
| Jul 1, 26 | Fairmount Funds Management LLC | other | 42,641 |
| Jul 1, 26 | Sandler Laura Lee | other | 5,000 |
| Jul 1, 26 | Sandler Laura Lee | sell | 2,237 |
| Jul 1, 26 | Sandler Laura Lee | sell | 2,263 |
| Jul 1, 26 | Sandler Laura Lee | sell | 500 |
| Jul 1, 26 | Sandler Laura Lee | other | 5,000 |
| Jun 22, 26 | Agarwal Arjun | sell | 888 |
| Jun 22, 26 | Agarwal Arjun | sell | 699 |
Our ORKA coverage
Recent articles, reports, and earnings notes.
No research on ORKA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ORKA report →Similar companies
Peers in the same neighborhood.